-

Shareholder Alert: Robbins LLP Reminds Investors iQIYI, Inc. (IQ) Sued for Misleading Shareholders

SAN DIEGO & HAIDIAN DISTRICT, Beijing--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of iQIYI, Inc. (NASDAQ: IQ) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 29, 2018 and April 7, 2020. iQIYI provides online entertainment services under the iQIYI brand in China.

If you suffered a loss as a result of iQIYI's misconduct, click here.

iQIYI, Inc. (IQ) Accused of Misleading Shareholders

According to the complaint, in March 2018, iQIYI held its initial public offering ("IPO") offering approximately 125 million ADSs for $18 per share and raising approximately $2.25 billion in proceeds. In its Registration Statement, iQIYI touted impressive online revenue growth from 2015 to 2017 due to "increased attractiveness and efficiency of [its] advertising services." Following the IPO, iQIYI continuously touted its growing number of paying subscribing members as well as its increasing advertising services revenue. Despite auspicious financials, on April 7, 2020, Wolfpack Research released a report revealing iQIYI had misled investors and failed to disclose in its Registration Statement that: (i) iQIYI overstated its user numbers; (ii) iQIYI inflated its revenues; (iii) iQIYI inflated its expenses and prices of assets to conceal its revenue inflation; and (iv) iQIYI's misleading financial reporting created the appearance of a cash generative company. The report concluded "[iQIYI] was committing fraud well before its IPO in 2018 and has continued to do so ever since." On this news, ADSs of iQIYI fell almost 6% to close at $16.51 per ADS.

If you purchased iQIYI, Inc. (IQ) securities between March 29, 2018 and April 7, 2020, you have until June 15, 2020, to ask the court to be appointed lead plaintiff for the class.

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:IQ

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom